Search clinical trials for: sublingual immunotherapy

Total 4405 results

Mahidol University

Unknown

Cervical Ripening Before Endometrial Biopsy in Abnormal Uterine Bleeding Using Sublingual Misoprostol

Abnormal Uterine Bleeding Unrelated to Menstrual Cycle

Thailand
Pevion Biotech Ltd

Completed

Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection

Recurrent Vulvovaginal Candidiasis

Switzerland
National Cancer Institute (NCI)

Completed

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Melanoma | Neoplasm Metastasis

United States
Robert Negrin
National Institutes of Health (NIH)

Unknown

Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation

Multiple Myeloma | Blood and Marrow Transplant (BMT)

United States
Assistance Publique - Hôpitaux de Paris

Completed

Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

Glioblastoma

France
Laboratorios Leti, S.L.

Completed

Biological Standardization of Blomia Tropicalis Allergen Extract

Allergy to Mites

Spain
Anergis

Terminated

Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen (AN003)

Allergy | Allergic Rhinitis

Switzerland
Prof. Serge Leyvraz

Completed

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Melanoma (Skin)

Switzerland
Michael Morse, MD
Immunotope

Completed

A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer

Epithelial Ovarian, Tubal or Peritoneal Cancer

United States
H. Kim Lyerly
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease (CMV-BMT)

Allogeneic Stem Cell Transplantation

United States
George Albert Fisher

Completed

Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
Rigshospitalet, Denmark
TRYG Foundation

Completed

Study to Asses Efficacy of Intralymphatic Immunotherapy (ILIT)

Allergy

Denmark
Dr. Sami Ulus Children's Hospital

Completed

Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Hysteroscopy

Pain During Hysteroscopy

Turkey
National Cancer Institute (NCI)

Terminated

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Melanoma | Malignant Melanoma | Melanoma, Experimental

United States
United Allergy Services

Completed

The Efficacy & Safety of the UAS Immunotherapy Protocol

Perennial Allergic Rhinitis With Seasonal Variation

United States
Neovii Biotech

Completed

CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers (CASIMAS)

Neoplasms | Carcinoma | Cancer | Malignant Ascites

France, Germany, Italy, Spain
Royal Sussex County Hospital

Terminated

Mechanisms of Allergen Immunotherapy

Allergic Rhinitis

United Kingdom
Agenus Inc.

Terminated

Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer

Kidney Cancer | Renal Cell Carcinoma

United States, Canada
Agenus Inc.

Terminated

Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Agenus Inc.

Completed

Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

Renal Cell Carcinoma

United States, France, Poland, United Kingdom, Spain, Israel, Canada, Belgium, Norway, Sweden, Austria
Agenus Inc.

Completed

Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma

Malignant Melanoma

United States, Australia, Poland, Ukraine, United Kingdom, Russian Federation, Hungary, Italy, Sweden
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma (PTCL-06)

Lymphoma, T-Cell, Peripheral

Italy
Laboratorios Leti, S.L.

Completed

Biological Standardization of Lolium Perenne Allergen Extract

Allergy to Grass Pollen

Spain
Laboratorios Leti, S.L.

Completed

Biological Standardization of Poa Pratensis Allergen Extract

Allergy to Grass Pollen

Spain
Laboratorios Leti, S.L.

Completed

Biological Standardization of Dactylis Glomerata Allergen Extract

Allergy to Grass Pollen (Dactylis Glomerata)

Spain
Laboratorios Leti, S.L.

Completed

Biological Standardization of Secale Cereale Allergen Extract

Allergy to Grass Pollen (Secale Cereale)

Spain
M.D. Anderson Cancer Center
MedImmune LLC

Terminated

Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment

Head and Neck Cancer

United States
M.D. Anderson Cancer Center

Completed

Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS

Myelodysplastic Syndrome

United States
Azienda Ospedaliera Universitaria Senese
MedImmune LLC

Unknown

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Malignant Mesothelioma

Italy
Azienda Ospedaliera Universitaria Senese

Unknown

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

Malignant Mesothelioma

Italy
American University of Beirut Medical Center

Completed

Sublingual Versus Vaginal Misoprostol for Labor Induction at Term

Induction of Labor

Lebanon
UCB Pharma

Completed

Study of Epratuzumab in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
UCB Pharma

Completed

Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease

Systemic Lupus Erythematosus

United States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
McNeil AB

Completed

Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg

Tobacco Dependence

Sweden
People's Hospital of Guangxi

Unknown

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer

Small Cell Lung Cancer

China
People's Hospital of Guangxi

Unknown

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Tufts Medical Center
University of Minnesota

Completed

Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions

Lymphoma | Leukemia | Myeloma

United States
Rennes University Hospital
Innate Pharma

Terminated

Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells (ICAR)

Hepatocellular Carcinoma

France
National Cancer Institute (NCI)

Completed

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Rhabdomyosarcoma | Ewing's Sarcoma

United States
VIVUS LLC

Completed

Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo

Erectile Dysfunction

United States
Casa de Saúde São José

Completed

Effects of Sedatives on Sublingual Microcirculation of Patients With Septic Shock

Sepsis | Shock,

Brazil
UCB Pharma

Terminated

Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States, France, United Kingdom, Spain, Belgium, Netherlands, Canada, Brazil, Germany, Czech Republic, Italy
Rasha Mohammed Mohammed Badawi
Ain Shams University

Unknown

Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor

Postpartum Hemorrhage Prevention by Using Oxytocin Verses Misoprostol

Egypt
Medical University of Silesia

Completed

House Dust Mite SLIT in Elderly Patients

Allergic Rhinitis

Poland
Queensland Institute of Medical Research
National Health and Medical Research Council, Australia; Australian Department... and other collaborators

Completed

Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas (EPL)

Lymphoma

Australia
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

ToleroMune Ragweed Follow up Study

Rhinoconjunctivitis | Ragweed Allergy

Canada
Central European Cooperative Oncology Group

Terminated

Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma

Renal Cell Cancer

Austria
Mannkind Corporation

Terminated

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

Stage IV Melanoma | Stage III Melanoma

United States
University of Göttingen
Nordic Lymphoma Group; German High-Grade Non-Hodgkin's Lymphoma Study Group

Unknown

Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP (A-CHOP-14)

Extranodal NK/T-cell Lymphoma | Peripheral T Cell Lymphoma, Unspecified | Angioimmunoblastic Lymphadenopathy

Germany
CytoVac A/S

Completed

Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy (ALECSAT)

Hormone-refractory Prostate Cancer

Denmark

Search clinical trials for: sublingual immunotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations